Comment on: A review of the experience with pediatric written requests issued for oncology drug products.

Rose, Klaus; Grant-Kels, Jane M; Ettienne, Earl B; Tanjinatus, Oishi; Striano, Pasquale; Neubauer, David

Rose, Klaus; Grant-Kels, Jane M; Ettienne, Earl B; Tanjinatus, Oishi; Striano, Pasquale; Neubauer, David.

Afiliación

Rose K; klausrose Consulting, Pediatric Drug Development & More, Riehen, Switzerland.
Grant-Kels JM; Department of Dermatology, UConn Health, Farmington, Connecticut, USA.
Ettienne EB; College of Pharmacy, Howard University, Washington, District of Columbia, USA.
Tanjinatus O; College of Pharmacy, Howard University, Washington, District of Columbia, USA.
Striano P; Pediatric Neurology and Muscular Diseases Unit, Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health, 'G. Gaslini' Institute, University of Genova, Genova, Italy.
Neubauer D; Department of Child, Adolescent & Developmental Neurology, University Children's Hospital, Ljubljana, Slovenia.

Pediatr Blood Cancer ; 68(8): e28972, 2021 08.

Article en En | MEDLINE | ID: mdl-33619883

Asunto(s)

Oncología Médica; Preparaciones Farmacéuticas; Niño; Aprobación de Drogas; Humanos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Preparaciones Farmacéuticas / Oncología Médica Límite: Child / Humans Idioma: En Revista: Pediatr Blood Cancer Asunto de la revista: HEMATOLOGIA / NEOPLASIAS / PEDIATRIA Año: 2021 Tipo del documento: Article País de afiliación: Suiza

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google